サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530943

核酸アプタマー市場：世界の産業分析、シェア、成長、動向、予測、2024年～2034年

Nucleic Acid Aptamers Market - Global Industry Analysis, Share, Share, Growth, Trends, and Forecast 2024-2034

出版日
ページ情報
英文 174 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
核酸アプタマー市場：世界の産業分析、シェア、成長、動向、予測、2024年～2034年
出版日: 2024年06月28日
発行: Transparency Market Research
ページ情報: 英文 174 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

核酸アプタマー市場 - 調査範囲

TMRの調査レポート「核酸アプタマーの世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界の核酸アプタマー市場の収益と予測を提供しています。また、2024年から2034年までの世界の核酸アプタマー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、核酸アプタマー市場を推察しました。

市場スナップショット
2023年の市場金g飼う 2億1,990万米ドル
2034年の市場金額 12億米ドル
CAGR 17.2%

当レポートでは、世界の核酸アプタマー市場の競合情勢について調査しています。世界の核酸アプタマー市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界の核酸アプタマー市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020年～2034年

第5章 主要洞察

  • 技術の進歩
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第6章 世界の市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果 / 発展
  • 市場金額予測：タイプ別、2020年～2034年
    • DNAアプタマー
    • RNAアプタマー
    • XNAアプタマー
  • 市場の魅力：タイプ別

第7章 世界の市場分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果 / 発展
  • 市場金額予測：用途別、2020年～2034年
    • ドラッグデリバリー
    • 抗ウイルス療法
    • 病原体の認識
    • 病気の認識
    • 幹細胞マーカー
    • その他
  • 市場の魅力：用途別

第8章 世界の市場分析と予測：適応症別

  • イントロダクションと定義
  • 主な調査結果 / 発展
  • 市場金額予測：適応症別、2020年～2034年
    • ウイルス感染
    • がん
    • 眼科
    • その他
  • 市場の魅力：適応症別

第9章 世界の市場分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果 / 発展
  • 市場金額予測：エンドユーザー別、2020年～2034年
    • バイオ医薬品企業
    • 診断センター
    • CRO
    • その他
  • 市場の魅力：エンドユーザー別

第10章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：国別 / 地域別

第11章 北米の市場分析と予測

  • 米国
  • カナダ

第12章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域

第13章 アジア太平洋の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリア・ニュージーランド
  • その他アジア太平洋

第14章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第15章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第16章 競合情勢

  • 市場企業 - 競合マトリックス（企業階層と規模別）
  • 企業プロファイル
    • Aptagen Labs
    • Aptamer Group
    • Base Pair Biotechnologies
    • NeoVentures Biotechnology Inc.
    • Aptamer Sciences, Inc.
    • SomaLogic Operating Co., Inc.
    • AptaTargets SL.
    • Aptus Biotech S.L.
    • その他の有力企業
図表

List of Tables

  • Table 01: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 03: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 04: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 05: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 08: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 09: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 10: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 11: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 13: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 14: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 15: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 16: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 18: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 19: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 20: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 21: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 23: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 24: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 25: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 26: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 28: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 29: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 30: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users,

List of Figures

  • Figure 01: Nucleic Acid Aptamers Market Size, by Type, 2023
  • Figure 02: Nucleic Acid Aptamers Market share (%), by Type, 2023
  • Figure 03: Nucleic Acid Aptamers Market Size, by Application, 2023
  • Figure 04: Nucleic Acid Aptamers Market share (%), by Application, 2023
  • Figure 05: Nucleic Acid Aptamers Market Size, by Indication, 2023
  • Figure 06: Nucleic Acid Aptamers Market share (%), by Application, 2023
  • Figure 07: Nucleic Acid Aptamers Market Size, by End-users, 2023
  • Figure 08: Nucleic Acid Aptamers Market share (%), by End-users, 2023
  • Figure 09: Global Nucleic Acid Aptamers Market, By Region (2023 and 2034)
  • Figure 10: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 11: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 12: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023
  • Figure 13: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2034
  • Figure 14: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 15: Global Nucleic Acid Aptamers Market Value (US$ Mn), by DNA Aptamer, 2020-2034
  • Figure 16: Global Nucleic Acid Aptamers Market Value Share Analysis, by DNA Aptamer, 2023 and 2034
  • Figure 17: Global Nucleic Acid Aptamers Market Value (US$ Mn), by RNA Aptamer, 2020-2034
  • Figure 18: Global Nucleic Acid Aptamers Market Value Share Analysis, RNA Aptamer, 2023 and 2034
  • Figure 19: Global Nucleic Acid Aptamers Market Value (US$ Mn), by XNA Aptamer, 2020-2034
  • Figure 20: Global Nucleic Acid Aptamers Market Value Share Analysis, by XNA Aptamer, 2023 and 2034
  • Figure 21: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 22: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023
  • Figure 23: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2034
  • Figure 24: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 25: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Drug-Delivery, 2020-2034
  • Figure 26: Global Nucleic Acid Aptamers Market Value Share Analysis, by Drug-Delivery, 2023 and 2034
  • Figure 27: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Anti-Viral Therapy, 2020-2034
  • Figure 28: Global Nucleic Acid Aptamers Market Value Share Analysis, Anti-Viral Therapy, 2023 and 2034
  • Figure 29: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Pathogen Recognition, 2020-2034
  • Figure 30: Global Nucleic Acid Aptamers Market Value Share Analysis, by Pathogen Recognition, 2023 and 2034
  • Figure 31: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Disease Recognition, 2020-2034
  • Figure 32: Global Nucleic Acid Aptamers Market Value Share Analysis, Disease Recognition, 2023 and 2034
  • Figure 33: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Stem Cell Markers, 2020-2034
  • Figure 34: Global Nucleic Acid Aptamers Market Value Share Analysis, by Stem Cell Markers, 2023 and 2034
  • Figure 35: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
  • Figure 36: Global Nucleic Acid Aptamers Market Value Share Analysis, Others, 2023 and 2034
  • Figure 37: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 38: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023
  • Figure 39: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2034
  • Figure 40: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 41: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Viral Infection, 2020-2034
  • Figure 42: Global Nucleic Acid Aptamers Market Value Share Analysis, by Viral Infection, 2023 and 2034
  • Figure 43: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Cancer, 2020-2034
  • Figure 44: Global Nucleic Acid Aptamers Market Value Share Analysis, Cancer, 2023 and 2034
  • Figure 45: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Ophthalmology, 2020-2034
  • Figure 46: Global Nucleic Acid Aptamers Market Value Share Analysis, by Ophthalmology, 2023 and 2034
  • Figure 47: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
  • Figure 48: Global Nucleic Acid Aptamers Market Value Share Analysis, Others, 2023 and 2034
  • Figure 49: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 50: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023
  • Figure 51: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2034
  • Figure 52: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 53: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Biopharmaceutical Companies, 2020-2034
  • Figure 54: Global Nucleic Acid Aptamers Market Value Share Analysis, by Biopharmaceutical Companies, 2023 and 2034
  • Figure 55: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Diagnostic Centers, 2020-2034
  • Figure 56: Global Nucleic Acid Aptamers Market Value Share Analysis, Diagnostic Centers, 2023 and 2034
  • Figure 57: Global Nucleic Acid Aptamers Market Value (US$ Mn), by CROs, 2020-2034
  • Figure 58: Global Nucleic Acid Aptamers Market Value Share Analysis, by CROs, 2023 and 2034
  • Figure 59: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
  • Figure 60: Global Nucleic Acid Aptamers Market Value Share Analysis, Hospitals, 2023 and 2034
  • Figure 61: Global Nucleic Acid Aptamers Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 62: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 63: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 64: North America Nucleic Acid Aptamers Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 65: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Country, 2023-2034
  • Figure 66: North America Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 67: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 68: North America Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 69: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 70: North America Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 71: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 72: North America Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 73: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 74: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 75: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 76: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 77: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 78: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 79: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 80: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 81: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 82: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 83: Europe Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 84: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 85: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 86: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 87: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 88: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 89: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 90: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 91: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 92: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 93: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 94: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 95: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 96: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 97: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 98: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 99: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 100: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 101: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 102: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 103: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 104: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 105: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 106: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 107: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 108: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 109: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 110: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 111: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 112: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 113: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 114: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 115: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 116: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 117: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
目次
Product Code: TMRGL1330

Nucleic Acid Aptamers Market - Scope of Report

TMR's report on the global nucleic acid aptamers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global nucleic acid aptamers market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nucleic acid aptamers market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nucleic acid aptamers market.

Market Snapshot
Market Value in 2023US$ 219.9 Mn
Market Value in 2034US$ 1.2 Bn
CAGR17.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nucleic acid aptamers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nucleic acid aptamers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nucleic acid aptamers market.

The report delves into the competitive landscape of the global nucleic acid aptamers market. Key players operating in the global nucleic acid aptamers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nucleic acid aptamers market profiled in this report.

Key Questions Answered in Global nucleic acid aptamers Market Report:

  • What is the sales/revenue generated by nucleic acid aptamers across all regions during the forecast period?
  • What are the opportunities in the global nucleic acid aptamers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nucleic Acid Aptamers Market - Research Objectives and Research Approach

The comprehensive report on the global nucleic acid aptamers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nucleic acid aptamers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nucleic acid aptamers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nucleic Acid Aptamers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Type Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nucleic Acid Aptamers Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. PORTERs Five Forces Analysis
  • 5.3. Value Chain Analysis

6. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2034
    • 6.3.1. DNA Aptamer
    • 6.3.2. RNA Aptamer
    • 6.3.3. XNA Aptamer
  • 6.4. Market Attractiveness By Type

7. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Drug Delivery
    • 7.3.2. Anti-viral Therapy
    • 7.3.3. Pathogen Recognition
    • 7.3.4. Disease Recognition
    • 7.3.5. Stem Cell Markers
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Indication, 2020-2034
    • 8.3.1. Viral infection
    • 8.3.2. Cancer
    • 8.3.3. Ophthalmology
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Indication

9. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Biopharmaceutical Companies
    • 9.3.2. Diagnostic Centers
    • 9.3.3. CROs
    • 9.3.4. Others
  • 9.4. Market Attractiveness By End-user

10. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Nucleic Acid Aptamers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2034
    • 11.2.1. DNA Aptamer
    • 11.2.2. RNA Aptamer
    • 11.2.3. XNA Aptamer
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Drug-Delivery
    • 11.3.2. Anti-viral Therapy
    • 11.3.3. Pathogen Recognition
    • 11.3.4. Disease Recognition
    • 11.3.5. Stem Cell Markers
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Indication, 2020-2034
    • 11.4.1. Viral infection
    • 11.4.2. Cancer
    • 11.4.3. Ophthalmology
    • 11.4.4. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Biopharmaceutical Companies
    • 11.5.2. Diagnostic Centers
    • 11.5.3. CROs
    • 11.5.4. Others
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Application
    • 11.7.3. By Indication
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Nucleic Acid Aptamers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2034
    • 12.2.1. DNA Aptamer
    • 12.2.2. RNA Aptamer
    • 12.2.3. XNA Aptamer
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Drug-Delivery
    • 12.3.2. Anti-viral Therapy
    • 12.3.3. Pathogen Recognition
    • 12.3.4. Disease Recognition
    • 12.3.5. Stem Cell Markers
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Indication, 2020-2034
    • 12.4.1. Viral infection
    • 12.4.2. Cancer
    • 12.4.3. Ophthalmology
    • 12.4.4. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Biopharmaceutical Companies
    • 12.5.2. Diagnostic Centers
    • 12.5.3. CROs
    • 12.5.4. Others
  • 12.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Application
    • 12.7.3. By Indication
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Nucleic Acid Aptamers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2034
    • 13.2.1. DNA Aptamer
    • 13.2.2. RNA Aptamer
    • 13.2.3. XNA Aptamer
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Drug-Delivery
    • 13.3.2. Anti-viral Therapy
    • 13.3.3. Pathogen Recognition
    • 13.3.4. Disease Recognition
    • 13.3.5. Stem Cell Markers
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Indication, 2020-2034
    • 13.4.1. Viral infection
    • 13.4.2. Cancer
    • 13.4.3. Ophthalmology
    • 13.4.4. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Biopharmaceutical Companies
    • 13.5.2. Diagnostic Centers
    • 13.5.3. CROs
    • 13.5.4. Others
  • 13.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Application
    • 13.7.3. By Indication
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Nucleic Acid Aptamers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2034
    • 14.2.1. DNA Aptamer
    • 14.2.2. RNA Aptamer
    • 14.2.3. XNA Aptamer
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Drug-Delivery
    • 14.3.2. Anti-viral Therapy
    • 14.3.3. Pathogen Recognition
    • 14.3.4. Disease Recognition
    • 14.3.5. Stem Cell Markers
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Indication, 2020-2034
    • 14.4.1. Viral infection
    • 14.4.2. Cancer
    • 14.4.3. Ophthalmology
    • 14.4.4. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Biopharmaceutical Companies
    • 14.5.2. Diagnostic Centers
    • 14.5.3. CROs
    • 14.5.4. Others
  • 14.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Application
    • 14.7.3. By Indication
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Nucleic Acid Aptamers Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Type, 2020-2034
    • 15.2.1. DNA Aptamer
    • 15.2.2. RNA Aptamer
    • 15.2.3. XNA Aptamer
  • 15.3. Market Value Forecast By Application, 2020-2034
    • 15.3.1. Drug-Delivery
    • 15.3.2. Anti-viral Therapy
    • 15.3.3. Pathogen Recognition
    • 15.3.4. Disease Recognition
    • 15.3.5. Stem Cell Markers
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Indication, 2020-2034
    • 15.4.1. Viral infection
    • 15.4.2. Cancer
    • 15.4.3. Ophthalmology
    • 15.4.4. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Biopharmaceutical Companies
    • 15.5.2. Diagnostic Centers
    • 15.5.3. CROs
    • 15.5.4. Others
  • 15.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Type
    • 15.7.2. By Application
    • 15.7.3. By Indication
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Aptagen Labs
      • 16.2.1.1. Company Overview
      • 16.2.1.2. Financial Overview
      • 16.2.1.3. Product Portfolio
      • 16.2.1.4. Business Strategies
      • 16.2.1.5. Recent Developments
    • 16.2.2. Aptamer Group
      • 16.2.2.1. Company Overview
      • 16.2.2.2. Financial Overview
      • 16.2.2.3. Product Portfolio
      • 16.2.2.4. Business Strategies
      • 16.2.2.5. Recent Developments
    • 16.2.3. Base Pair Biotechnologies
      • 16.2.3.1. Company Overview
      • 16.2.3.2. Financial Overview
      • 16.2.3.3. Product Portfolio
      • 16.2.3.4. Business Strategies
      • 16.2.3.5. Recent Developments
    • 16.2.4. NeoVentures Biotechnology Inc.
      • 16.2.4.1. Company Overview
      • 16.2.4.2. Financial Overview
      • 16.2.4.3. Product Portfolio
      • 16.2.4.4. Business Strategies
      • 16.2.4.5. Recent Developments
    • 16.2.5. Aptamer Sciences, Inc.
      • 16.2.5.1. Company Overview
      • 16.2.5.2. Financial Overview
      • 16.2.5.3. Product Portfolio
      • 16.2.5.4. Business Strategies
      • 16.2.5.5. Recent Developments
    • 16.2.6. SomaLogic Operating Co., Inc.
      • 16.2.6.1. Company Overview
      • 16.2.6.2. Financial Overview
      • 16.2.6.3. Product Portfolio
      • 16.2.6.4. Business Strategies
      • 16.2.6.5. Recent Developments
    • 16.2.7. AptaTargets SL.
      • 16.2.7.1. Company Overview
      • 16.2.7.2. Financial Overview
      • 16.2.7.3. Product Portfolio
      • 16.2.7.4. Business Strategies
      • 16.2.7.5. Recent Developments
    • 16.2.8. Aptus Biotech S.L.
      • 16.2.8.1. Company Overview
      • 16.2.8.2. Financial Overview
      • 16.2.8.3. Product Portfolio
      • 16.2.8.4. Business Strategies
      • 16.2.8.5. Recent Developments
    • 16.2.9. Other Prominent Players
      • 16.2.9.1. Company Overview
      • 16.2.9.2. Financial Overview
      • 16.2.9.3. Product Portfolio
      • 16.2.9.4. Business Strategies
      • 16.2.9.5. Recent Developments